A detailed history of Vectors Research Management, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Vectors Research Management, LLC holds 5,759 shares of JNJ stock, worth $949,198. This represents 0.26% of its overall portfolio holdings.

Number of Shares
5,759
Previous 5,664 1.68%
Holding current value
$949,198
Previous $896,000 6.03%
% of portfolio
0.26%
Previous 0.25%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$144.38 - $157.78 $13,716 - $14,989
95 Added 1.68%
5,759 $842,000
Q1 2024

May 14, 2024

SELL
$155.22 - $162.74 $32,751 - $34,338
-211 Reduced 3.59%
5,664 $896,000
Q4 2023

Feb 12, 2024

SELL
$145.6 - $158.88 $5,824 - $6,355
-40 Reduced 0.68%
5,875 $924,000
Q3 2023

Nov 09, 2023

SELL
$155.75 - $174.48 $126,936 - $142,201
-815 Reduced 12.11%
5,915 $902,000
Q2 2023

Aug 08, 2023

BUY
$154.35 - $166.11 $31,641 - $34,052
205 Added 3.14%
6,730 $1.11 Million
Q1 2023

May 04, 2023

SELL
$151.05 - $180.26 $39,575 - $47,228
-262 Reduced 3.86%
6,525 $1.01 Million
Q4 2022

Feb 08, 2023

BUY
$160.2 - $179.79 $23,389 - $26,249
146 Added 2.2%
6,787 $1.2 Million
Q3 2022

Nov 08, 2022

SELL
$161.33 - $179.52 $23,070 - $25,671
-143 Reduced 2.11%
6,641 $1.09 Million
Q2 2022

Aug 12, 2022

SELL
$168.19 - $186.01 $91,495 - $101,189
-544 Reduced 7.42%
6,784 $1.2 Million
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $326,875 - $371,212
-2,067 Reduced 22.0%
7,328 $1.3 Million
Q4 2021

Feb 15, 2022

BUY
$155.93 - $173.01 $65,802 - $73,010
422 Added 4.7%
9,395 $1.61 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $80,427 - $89,376
-498 Reduced 5.26%
8,973 $1.45 Million
Q2 2021

Aug 09, 2021

SELL
$159.48 - $171.07 $22,965 - $24,634
-144 Reduced 1.5%
9,471 $1.56 Million
Q1 2021

May 18, 2021

SELL
$153.07 - $170.48 $76,075 - $84,728
-497 Reduced 4.91%
9,615 $1.58 Million
Q4 2020

Feb 09, 2021

BUY
$137.11 - $157.38 $362,107 - $415,640
2,641 Added 35.35%
10,112 $1.59 Million
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $108,232 - $118,602
-771 Reduced 9.35%
7,471 $1.11 Million
Q2 2020

Aug 13, 2020

BUY
$128.81 - $155.51 $257 - $311
2 Added 0.02%
8,242 $1.16 Million
Q1 2020

May 14, 2020

SELL
$111.14 - $153.99 $98,136 - $135,973
-883 Reduced 9.68%
8,240 $1.08 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $127 - $146
1 Added 0.01%
9,123 $1.33 Million
Q3 2019

Nov 15, 2019

SELL
$126.95 - $142.14 $27,802 - $31,128
-219 Reduced 2.34%
9,122 $1.18 Million
Q2 2019

Aug 12, 2019

SELL
$131.15 - $144.24 $38,820 - $42,695
-296 Reduced 3.07%
9,341 $1.3 Million
Q1 2019

Jul 15, 2019

BUY
$125.72 - $139.79 $387,971 - $431,391
3,086 Added 47.11%
9,637 $1.35 Million
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $367,168 - $441,893
-2,989 Reduced 31.33%
6,551 $845,000
Q3 2018

Nov 15, 2018

BUY
$121.58 - $142.88 $1.16 Million - $1.36 Million
9,540 New
9,540 $1.16 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $431B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Vectors Research Management, LLC Portfolio

Follow Vectors Research Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vectors Research Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vectors Research Management, LLC with notifications on news.